Barrington Research analyst Michael Petusky maintains US Physical Therapy (NYSE:USPH) with a Outperform and raises the price target from $120 to $122.
Barrington Research Maintains Outperform on US Physical Therapy, Raises Price Target to $122
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.